Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells
Anticancer Research · 2026
DOI: 10.21873/anticanres.18133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Wei-Chun Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Apoptosis, Mouth Neoplasms, Imipramine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.
- Department of Medical Imaging and Radiological Science, Central Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C.
- Department of Dentistry, Dental School, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.
- Department of Life Sciences, National Central University, Taoyuan, Taiwan, R.O.C.
- Department of Medical Imaging and Radiological Science, Central Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C.; 108653@ctust.edu.tw.
- Department of Dentistry, Dental School, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.; hftu@nycu.edu.tw.
Zitieren
APA
Wang, W. C., Chen, Y. T., Hsu, F. T., Peng, B. R., & Tu, H. F. (2026). Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells. Anticancer Research. https://doi.org/10.21873/anticanres.18133
Vancouver
Wang WC, Chen YT, Hsu FT, Peng BR, Tu HF. Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells. Anticancer Research. 2026. doi:10.21873/anticanres.18133
BibTeX
@article{Wang2026,
author = {Wang, Wei-Chun and Chen, Ying-Tzu and Hsu, Fei-Ting and Peng, Bing-Ru and Tu, Hsi-Feng},
title = {Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18133}
}
EUVIMED